Lutein by Scleral Iontophoresis in AMD
NCT06925893 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2025-04-13
Summary
The objective of the clinical investigation is to evaluate the performance, safety and degree of tolerability resulting from the use of the iontophoresis medical device in adult subjects diagnosed with AMD stage 3 (AREDS classification) in one or both eyes.
Conditions
- Stage 3 AMD
Sponsors & Collaborators
-
Federico II University
lead OTHER
Eligibility
- Min Age
- 55 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-11-01
- Primary Completion
- 2024-12-01
- Completion
- 2025-12-01
Countries
- Italy
Study Locations
More Related Trials
-
Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration
NCT05005884 ·Status: UNKNOWN ·Phase: PHASE1
-
Effects of Sun Filters on Age-related Macular Degeneration in People With Lens Implants
NCT00487838 ·Status: WITHDRAWN
-
Evaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry Age-Related Macular Degeneration Patients
NCT06582511 ·Status: ACTIVE_NOT_RECRUITING
-
Lutein for Age-Related Macular Degeneration
NCT00006202 ·Status: COMPLETED ·Phase: PHASE2
-
Oxidative Stress in Patients With Age-Related Macular Degeneration
NCT00465400 ·Status: COMPLETED
-
The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract
NCT06365762 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)
NCT03946085 ·Status: COMPLETED ·Phase: NA
-
Age-Related Macular Degeneration, Scotopic Dysfunction, and Driving Performance in a Simulator
NCT03166202 ·Status: COMPLETED
-
Effects of Lutein in Retinitis Pigmentosa
NCT00029289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of Macular Pigment in Patients With Age-related Macular Degeneration
NCT00494325 ·Status: COMPLETED
-
Relationships Between Macular Pigment Optical Density and Lacquer Cracks in High Myopic Patients.
NCT02205632 ·Status: COMPLETED ·Phase: NA
-
Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation
NCT01404845 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
NCT00346333 ·Status: COMPLETED ·Phase: PHASE3
-
Age-related Macular Degeneration (AMD) and Cardiovascular Disease
NCT04087356 ·Status: UNKNOWN
-
Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients With Age-related Macular Degeneration
NCT00879671 ·Status: COMPLETED ·Phase: NA
-
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)
NCT00763659 ·Status: COMPLETED ·Phase: NA
-
The Influence of Lutein Supplements on Age-related Macular Degeneration
NCT01042860 ·Status: COMPLETED ·Phase: NA
-
Age-Related Eye Disease Study (AREDS) Follow-Up
NCT00594672 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration
NCT01048476 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Macular Pigment and Glare Disability
NCT00909090 ·Status: COMPLETED ·Phase: NA
-
Mitochondrial DNA in Vitreous Fluid and Blood in Patients With Eye Disease or Ocular Trauma.
NCT04334499 ·Status: WITHDRAWN
-
Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
NCT06965426 ·Status: RECRUITING ·Phase: NA
-
Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration
NCT01528605 ·Status: COMPLETED ·Phase: NA
-
Dark Adaptation in Participants With Age-Related Macular Degeneration
NCT03225131 ·Status: ACTIVE_NOT_RECRUITING
-
Randomized Controlled Trial of LUtein as a Novel Neuroprotective Adjunctive Therapy to Improve Visual Outcome of Rhegmatogenous Retinal Detachment (LUNAR Study)
NCT03932305 ·Status: COMPLETED ·Phase: NA